Illumina vs Zoetis

Illumina (ILMN), health care, and Zoetis (ZTS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Zoetis is worth $33.9B on the stock market and Illumina $30.6B: Zoetis is valued at 11% more. Illumina trades at 34.1 times earnings and Zoetis at 14.3. Over the past year Illumina's share price has moved +62.3% and Zoetis's -28.6%.

Key facts

Illumina market value
$30.6B
Zoetis market value
$33.9B
Illumina P/E
34.1
Zoetis P/E
14.3
Illumina revenue
$4.3BFY to 2025-12-28
Zoetis revenue
$9.5BFY to 2025-12-31
Superinvestors holding both
2

Market values as of .

Illumina vs Zoetis: every measure side by side
Measure Illumina Zoetis
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-282025-12-31
Size
Market cap$30.6Blower$33.9Bhigher
Revenue$4.3Blower$9.5Bhigher
Earnings$850Mlower$2.7Bhigher
Employees8,600lower14,500higher
Total assets$6.6Blower$15.5Bhigher
Valuation
P/E34.1higher14.3lower
P/S7.1higher3.6lower
P/B9.8lower10.3higher
Dividend yield0.00%lower2.48%higher
Profitability
Operating margin18.6%—
Balance sheet
Net assets$2.7Blower$3.3Bhigher
Total liabilities$3.9Blower$12.1Bhigher
Total debt—$9B
Cash on hand$1.4Blower$2.3Bhigher
Price change
Today+2.33%higher-1.08%lower
1 year+62.3%higher-28.6%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Illumina / Zoetis). Who owns ILMN · Who owns ZTS

Further comparisons

Learn

Questions and answers

Which is bigger, Illumina or Zoetis?

By market value, Zoetis is the larger: $33.9B against $30.6B for Illumina. By revenue in its latest fiscal year, Zoetis is the larger: $9.5B against $4.3B for Illumina.

Which has the higher P/E ratio?

Illumina: 34.1, against 14.3 for Zoetis. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher dividend yield?

Zoetis: 2.48%, against 0.00% for Illumina. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Illumina and Zoetis?

In their latest 13F filings, Diamond Hill team and Jim Simons (1938–2024) hold both.

Cite this page

Funkfolio, “Illumina vs Zoetis”, data as of 18 November 2026. https://funkfolio.com/compare/ilmn-vs-zts

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.